Gender Equity Committee

Mission

In 2021, the Gender Equity Committee was established at HDFCCC to promote and foster a supportive environment that advocates for the equitable advancement of women and gender minority leaders in cancer care, education, and research. The Gender Equity Committee is a sub-committee within the Office of Diversity, Equity, Inclusion, and Accessibility

Goals

  • Advocating for gender equity across divisions and departments included in the Cancer Center
  • Building/establishing bi-directional partnerships across the Cancer Center
  • Sponsoring career development and fostering leadership training
  • Educating the Cancer Center community and broader network of the cancer research community about gender equity
  • Identifying needs of the Cancer Center community related to gender equity and developing metrics of success

Latest News

Lauren Boreta, MD
Co-Chair, Gender Equity Committee
Assistant Professor, Department of Radiation Oncology

Bridget Keenan, MD, PhD

Bridget Keenan, MD, PhD
Co-Chair, Gender Equity Committee
Assistant Professor, Division of Hematology & Oncology

Dr. Bridget Keenan has been at UCSF since 2015, first as a resident in Internal Medicine, then as a fellow in Hematology/Oncology, and recently, as faculty in the Division of Hematology/Oncology. She is a medical oncologist and physician-scientist, with a background in immunology and tumor immunotherapy. Her clinical role is in the Cancer Immunotherapy Clinic, where she cares for patients with solid organ tumors who are seeking or enrolled in immunotherapy clinical trials. Her research investigates mechanisms of the immune system to treat gastrointestinal malignancies. Dr. Keenan has had a long-standing interest in equity and working with underserved communities, and was involved with several community organizations in Baltimore during college and medical school. She has a particular focus on gender equity in science and medicine. At UCSF, she was the co-founder of Women in Leadership Development and is a current Co-Chair of the HDFCCC Gender Equity Committee.

Ana Velázquez Mañana

Ana I. Velázquez Mañana, MD, MSc, FASCO
Vice Chair, Gender Equity Committee
HDFCCC Office of DEIA Liaison
Assistant Professor, Division of Hematology & Oncology at ZSFGH

Dr. Velázquez joined UCSF in 2018 as a clinical fellow of Medicine and in 2022 was appointed as an assistant professor of Medicine in the Division of Hematology/Oncology at Zuckerberg San Francisco General Hospital. During her clinical training, she focused on thoracic oncology, with a special interest in the care of vulnerable populations with cancer. Since 2019, Dr. Velázquez has been an active member of the American Society of Clinical Oncology (ASCO) Trainee and Early Career Advisory Group. Over the past two years, she has served as co-leader of the ASCO Oncology Summer Internship at UCSF, a clinical summer program for underrepresented medical students aimed at increasing diversity of the oncology workforce.

Amanda Sibley, MPH, PhD
HDFCCC Executive Leadership Liaison
Director of Strategic Initiatives, HDFCCC

Katherine Van Loon, MD, MPH
Senior Advisor, Gender Equity Committee
Professor, Department of Medicine

2024-2025 Members

2023-2024 Members

 

Anonymous

  • UCSF CARE Advocate: The CARE advocate provides free and confidential services and explanation of each reporting option in details. This can be your first stop to discuss any issue confidentially, and they can support you to decide any next steps.
  • UCSF Office of the Ombuds: This office can provide survivors with confidential information, including other resources. They can provide counseling and mediate difficult conversations. They are not mandatory reporters.
  • UC Whistleblower: If you suspect that a UC employee is engaged in improper governmental activities, you should know that UC has policies that can show you how to "blow the whistle" and can protect you from retaliation if the need arises.  

Not Anonymous

  • Mandated reporters - managers, supervisors and certain employees, such as deans, faculty advisors, teaching assistants and resident advisors are required to report to the Title IX officer.
  • Office for the Prevention of Harassment & Discrimination (OPHD): UCSF’s Title IX Office.
    • This is where you file complaints relating to sexual harassment and sexual violence and harassment and discrimination based on other protected categories, including age, disability, gender, national origin, race, sexual orientation, etc.
    • Staffed by experts who will respond within a few days of receiving the complaint
    • If you submit a complaint as a mandatory reporter, you may not be notified of the outcome. 
    • Reports submitted to OPHD are kept as confidential as possible; however, a respondent has the right to know the identity of the complainant whenever a matter proceeds to a formal investigation. 
    • Encourage erring on the side of reporting, as complaints are logged and numerous reports of seemingly innocuous behavior may reveal a pattern of behavior that cumulatively results in a policy violation. 

Process for UCSF residents/fellows to report harassment or mistreatment:

  1. Go to the UCSF GME website.
  2. Click on “Well-Being and Mental Health Resources for Residents and Fellows” in the right sidebar
  3. Click the “Safe reporting” link in the right sidebar.
  • You can report an incident either anonymously or with contact information.
  • The form to report the incident is easy to use and the only required question is a description of what happened.
  • All reports are screened by GME staff, then (per the website) triaged to a faculty member unrelated to the submitting resident/fellow’s program for follow up.
  • Although reports can be submitted anonymously, contact information is required for follow up, which should occur within 3 business days.
  1. McGourty CA, Castillo F, Donzelli G, Keenan BP, Gilbreth M, Santhosh L. Creation of a sustainable longitudinal women in Leadership Development (WILD) curriculum focused on graduate medical education trainees. BMC Med Educ. 2024 Apr 5;24(1):374. doi: 10.1186/s12909-024-05369-3. PMID: 38580971; PMCID: PMC10996076.
  2. Keenan BP, Sibley A, Zhang L, Westring AF, Velazquez AI, Bank EM, Bergsland EK, Boreta L, Conroy P, Daras M, Hermiston M, Hsu G, Paris PL, Piawah S, Sinha S, Sosa JA, Tsang M, Venook AP, Wong M, Yom SS, Van Loon K. Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center. Oncologist. 2024 Mar 4;29(3):e351-e359. doi: 10.1093/oncolo/oyad194. PMID: 37440206; PMCID: PMC10911925.
  3. Majmudar S, Graff SL, Kays M, Braz BX, Matt-Amaral L, Markham MJ, Subbiah IM, Bergsland E, Jain S. The Careers and Professional Well-Being of Women Oncologists During the COVID-19 Pandemic: Responding for Tomorrow. J Med Internet Res. 2023 Aug 21;25:e47784. doi: 10.2196/47784. PMID: 37603399; PMCID: PMC10477917.
  4. Idossa D, Velazquez AI, Horiguchi M, Alberth J, Abuali I, Smith-Graziani D, de Lima Lopes G, Lubner S, Florez N. Mentorship Experiences Are Not All the Same: A Survey Study of Oncology Trainees and Early-Career Faculty. JCO Oncol Pract. 2023 Sep;19(9):808-818. doi: 10.1200/OP.22.00643. Epub 2023 May 16. PMID: 37192431; PMCID: PMC10860955.
  5. Keenan BP, Barr E, Gleeson E, Greenberg CC, Temkin SM. Structural Sexism and Cancer Care: The Effects on the Patient and Oncologist. Am Soc Clin Oncol Educ Book. 2023 May;43:e391516. doi: 10.1200/EDBK_391516. PMID: 37155944.
  6. Velazquez AI, Gilligan TD, Kiel LL, Graff J, Duma N. Microaggressions, Bias, and Equity in the Workplace: Why Does It Matter, and What Can Oncologists Do? Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-12. doi: 10.1200/EDBK_350691. PMID: 35649205.
  7. Patel SR, St Pierre F, Velazquez AI, Ananth S, Durani U, Anampa-Guzmán A, Castillo K, Dhawan N, Oxentenko AS, Duma N. The Matilda Effect: Underrecognition of Women in Hematology and Oncology Awards. Oncologist. 2021 Sep;26(9):779-786. doi: 10.1002/onco.13871. Epub 2021 Jul 9. PMID: 34157172; PMCID: PMC8417845.
  8. Keenan B, Jagsi R, Van Loon K. Pragmatic Solutions to Counteract the Regressive Effects of the COVID-19 Pandemic for Women in Academic Oncology. JAMA Oncol. 2021 Jun 1;7(6):825-826. doi: 10.1001/jamaoncol.2020.7681. PMID: 33570543.
  9. Santhosh L, Harleman E, Venado A, Farrand E, E Gilbreth M, Keenan BP, Thompson VV, Shah RJ. Strategies for forming effective women's groups. Clin Teach. 2021 Apr;18(2):126-130. doi: 10.1111/tct.13277. Epub 2020 Oct 15. PMID: 33058547.
  10. Santhosh L, Keenan BP, Jain S. The "Third Shift": A Path Forward to Recognizing and Funding Gender Equity Efforts. J Womens Health (Larchmt). 2020 Nov;29(11):1359-1360. doi: 10.1089/jwh.2020.8679. Epub 2020 Jul 31. PMID: 32744885; PMCID: PMC8020533.
  11. Keenan B, Santhosh L, Thompson V, Harleman E. The Complex Problem of Women Trainees in Academic Medicine. J Hosp Med. 2019 Mar;14(3):186-188. doi: 10.12788/jhm.3131. PMID: 30811328.